Erin Dean, MD

Oncologist, Cellular Immunotherapy/BMT, @UCIrvineHealth @ChaoCompCancer

[Erin Dean, MD @ErinDeanMD]

▶️Lifesaving cancer treatment without life-threatening side effects https://t.co/SWAyT4DIY4

[Erin Dean, MD @ErinDeanMD]

▶️Repurposing mitochondrial-targeting drugs for management of ICANS in CAR T-cell therapy: a novel steroid-sparing approach
https://t.co/tIm6EdsOkl

[Blood Journals Portfolio @BloodPortfolio]

New episode of the Blood Podcast out now! Drs. Matthew Frank of @StanfordMed and Jieqing Zhu of @BloodCenterWI discuss their latest papers published in Blood. Listen to "HLH-like toxicities after CAR-T and Structure-Function Relationships of FNAIT" here:
https://t.co/1FmkcYjU6G

[Pharmaceuticals MDPI @Pharmaceut_MDPI]

📢#Specialissue: Optimizing #Immunotherapeutic Strategies for #Hematologic #Malignancies
⏰Deadline: 31 October 2026
🎓Guest Editors: Dr. Erin Alexis Dean, Dr. Victoria S. Brown and Dr. Dina Khalaf
📖Find out more at https://t.co/5Y7y7nhohe @MDPIBiologySubj

[Erin Dean, MD @ErinDeanMD]

CAR T-cell therapy induced pseudoprogression
https://t.co/wHgsVJ7gIC

[ChaoCompCancerCenter @ChaoCompCancer]

The Chao Family Comprehensive Cancer Center is one of only 57 National Cancer Institute (NCI)-designated comprehensive cancer centers in the United States, and the only one based in Orange County.

[MOASC @MOASC_Office]

Advances in CAR-T cell therapy and transplant take the spotlight with Dr. Erin Dean @uciphysicians, highlighting clinical progress and future directions #SpotlightOnHematology2026 #CART #hemeonc @ASH_hematology

[Erin Dean, MD @ErinDeanMD]

T-cell exhaustion due to BiTE therapy in multiple myeloma: mitigating infectious risks through treatment-free intervals
https://t.co/53QcaHdgye

[Pharmaceuticals MDPI @Pharmaceut_MDPI]

📢#Specialissue: Optimizing #Immunotherapeutic Strategies for #Hematologic Malignancies
⏰Deadline: 30 June 2026
🎓Guest Editors: Dr. Erin Alexis Dean et al.
📖Find out more at https://t.co/5Y7y7nhohe @MDPIBiologySubj

[HemOnc Today @HemOncToday]

‘Definitive’ data:

🦠 A #NeutropenicDiet reduces major #infection risk among hospitalized patients with #BloodCancer.

🗨️ “I wanted the results to be the opposite of what we found,” Dr. John R. Wingard @UFHealthCancer tells @GoHealio. https://t.co/OQ7Y5ToGWA

[Journal of Clinical Oncology @JCO_ASCO]

Randomized Noninferiority Trial of a Liberalized Diet Versus the Neutropenic Diet in Hematopoietic Stem-Cell Transplant Patients and Patients With Acute Leukemia.

Read the full article. https://t.co/Gn8tGyKtqu

[MOASC @MOASC_Office]

It's not too late to register for Spotlight on Hematology! See you in less than two weeks for a day of the latest research in the field!

[UF Medicine @UFMedicine]

A recent @UF College of Medicine, @UFPHHP and @UFHealthCancer study found clear evidence that a diet designed to limit exposure to foodborne microbes is safest for patients undergoing blood cancer treatment. Learn more: https://t.co/VeYDMqNhTv

[Erin Dean, MD @ErinDeanMD]

Growing evidence for the use of ctDNA in LBCL:
Remission Assessment by Circulating Tumor DNA in Large B-Cell Lymphoma | Journal of Clinical Oncology https://t.co/MCgSuJYlCi

[UCI Health @UCIrvineHealth]

We’re officially open!

UCI Health — Irvine is a next-generation, all-electric hospital designed for comfort, innovation and healing.
Welcome to a new era of care in Irvine.

#ucihealthirvine #irvinehospital #allelectrichospital #ucihealth

[Erin Dean, MD @ErinDeanMD]

SpaceX 🚀 launch in SoCal

[Erin Dean, MD @ErinDeanMD]

Frontiers | Soluble B-cell maturation antigen as a serum marker of MRD in patients with multiple myeloma🩸🧪

https://t.co/SFcKbJZDbk

[Erin Dean, MD @ErinDeanMD]

Understanding the immune response to bispecific antibodies🔬: Case Report: Reactive T-cell large granular lymphocytes in the bone marrow of a patient with relapsed/refractory multiple myeloma receiving teclistamab
https://t.co/Me4o6d0BaC

[Erin Dean, MD @ErinDeanMD]

“It was a tinkerer’s dream: a way to rewrite the intricate machinery of these cells”🔬

"Zelig Eshhar, Who Engineered Immune Cells to Fight Cancer, Dies at 84" from The New York Times. Read on @Doximity https://t.co/56257gMJmw